Compare · AVTR vs ENTG
AVTR vs ENTG
Side-by-side comparison of Avantor Inc. (AVTR) and Entegris Inc. (ENTG): market cap, price performance, sector, and recent activity on the wire.
Summary
- AVTR operates in Health Care, while ENTG operates in Industrials - the two are in different parts of the market.
- ENTG is the larger of the two at $19.03B, about 1.9x AVTR ($10.05B).
- ENTG has been more active in the news (6 items in the past 4 weeks vs 4 for AVTR).
- Both have 25 recent analyst ratings on file.
- Company
- Avantor Inc.
- Entegris Inc.
- Price
- -
- -
- Market cap
- $10.05B
- $19.03B
- 1M return
- -
- -2.90%
- 1Y return
- -
- +68.40%
- Industry
- Biotechnology: Laboratory Analytical Instruments
- Plastic Products
- Exchange
- NYSE
- NASDAQ
- IPO
- 2019
- 2000
- News (4w)
- 4
- 6
- Recent ratings
- 25
- 25
Avantor Inc.
Avantor, Inc. provides products and services to customers in biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, and clinical trial kits. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Avantor, Inc. was founded in 1904 and is headquartered in Radnor, Pennsylvania.
Entegris Inc.
Entegris, Inc. develops, manufactures, and supplies microcontamination control products, specialty chemicals, and advanced materials handling solutions for manufacturing processes in the semiconductor and other high-technology industries in North America, Taiwan, South Korea, Japan, China, Europe, and Southeast Asia. It operates through three segments: Specialty Chemicals and Engineered Materials (SCEM); Microcontamination Control (MC); and Advanced Materials Handling (AMH). The SCEM segment offers high-performance and high-purity process chemistries, gases, and materials, as well as delivery systems to support semiconductor and other advanced manufacturing processes. The MC segment provides solutions to filter and purify critical liquid chemistries and gases used in semiconductor manufacturing processes and other high-technology industries. The AMH segment develops solutions to monitor, protect, transport, and deliver critical liquid chemistries, wafers, and other substrates for application in the semiconductor and other high-technology industries. The company's customers include semiconductor device manufacturers, semiconductor equipment makers, gas and chemical manufacturing companies, and wafer grower companies; and flat panel display equipment makers, panel manufacturers, and manufacturers of hard disk drive components and devices and their related ecosystems. It also serves manufacturers and suppliers in the solar and life science industries, electrical discharge machining customers, glass and glass container manufacturers, aerospace manufacturers, and manufacturers of biomedical implantation devices. The company was founded in 1966 and is headquartered in Billerica, Massachusetts.
Latest AVTR
- EVP, Chief Operating Officer Blenn Mary covered exercise/tax liability with 2,900 shares, decreasing direct ownership by 1% to 250,484 units (SEC Form 4) to satisfy withholding obligation
- EVP, Chief Legal & Compliance Sokenu Claudius was granted 62,305 shares, increasing direct ownership by 25% to 313,533 units (SEC Form 4)
- EVP, Chief HR Officer Hankamer Brittany was granted 46,728 shares, increasing direct ownership by 19% to 295,592 units (SEC Form 4)
- Avantor Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
- SEC Form 10-Q filed by Avantor Inc.
- SEC Form 8-K filed by Avantor Inc.
- Avantor® Reports Third Quarter 2026 Results
- Avantor appoints new Chief Information Officer
- Healthcare Stocks Rushing Higher, with Oncology Push, Breakout Test, and Lilly’s Next Growth Chapter
- Avantor® to Report Third Quarter 2026 Earnings on Wednesday, October 28, 2026
Latest ENTG
- Amendment: SEC Form SCHEDULE 13G/A filed by Entegris Inc.
- Entegris Inc. filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
- Entegris Details Growth Strategy and Long-Term Financial Model at 2026 Capital Markets Day
- Where Chip Charts Stand After Today's Slide, and What Their Latest Earnings Reports Said
- Entegris Expands Strategic Partnership with Kioxia to Accelerate Materials Innovation for Next-Generation Memory in the AI Era
- Entegris Enters Silicon Carbide and Diamond-Enabled Thermal Management Materials Market for AI Advanced Packaging
- SEC Form 10-Q filed by Entegris Inc.
- SEC Form 8-K filed by Entegris Inc.
- Entegris Reports Results for Third Quarter of 2026
- Truist initiated coverage on Entegris with a new price target